Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Neon Therapeutics, Inc. (NTGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/06/2020 |
4
| Zausner Meryl (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
Disposed/sold 40,000 options to buy
@ $9.65, valued at
$386k
Disposed/sold 14,000 options to buy
@ $16, valued at
$224k
|
|
| 05/06/2020 |
4
| TEPPER ROBERT I (10% Owner) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 9,741,636 shares
@ $0
Disposed/sold 14,000 options to buy
@ $16, valued at
$224k
Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 05/06/2020 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 45,000 shares
@ $0
Disposed/sold 14,000 options to buy
@ $16, valued at
$224k
Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
Disposed/sold 5,000 options to buy
@ $2.65, valued at
$13.3k
|
|
| 05/06/2020 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 14,000 options to buy
@ $16, valued at
$224k
Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 05/06/2020 |
4
| LANDER ERIC S (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 134,000 shares
@ $0
Disposed/sold 14,000 options to buy
@ $16, valued at
$224k
Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 05/06/2020 |
4
| Kamen Robert (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 14,000 options to buy
@ $16, valued at
$224k
Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 05/06/2020 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 28,000 options to buy
@ $7.56, valued at
$211.7k
Disposed/sold 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 05/06/2020 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 210,410 shares
@ $0
Disposed/sold 58,005 options to buy
@ $10.2, valued at
$591.7k
Disposed/sold 105,000 options to buy
@ $6.13, valued at
$643.7k
Disposed/sold 155,373 options to buy
@ $2.65, valued at
$411.7k
|
|
| 05/06/2020 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 161,821 shares
@ $0
Disposed/sold 60,000 options to buy
@ $6.13, valued at
$367.8k
Disposed/sold 100,000 options to buy
@ $12, valued at
$1.2M
|
|
| 05/06/2020 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 196,965 shares
@ $0
Disposed/sold 192,759 options to buy
@ $5.8, valued at
$1.1M
Disposed/sold 61,031 options to buy
@ $10.2, valued at
$622.5k
Disposed/sold 100,000 options to buy
@ $6.13, valued at
$613k
|
|
| 05/06/2020 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Disposed/sold 776,085 shares
@ $0
Disposed/sold 208,062 options to buy
@ $10.2, valued at
$2.1M
Disposed/sold 200,000 options to buy
@ $6.13, valued at
$1.2M
Disposed/sold 354,632 options to buy
@ $2.65, valued at
$939.8k
|
|
| 03/25/2020 |
4
| Access Industries Holdings LLC (10% Owner) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Sold 117,400 shares
@ $2.2022, valued at
$258.5k
Sold 84,286 shares
@ $2.1923, valued at
$184.8k
Sold 50,358 shares
@ $2.1741, valued at
$109.5k
|
|
| 03/23/2020 |
4
| Access Industries Holdings LLC (10% Owner) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Sold 84,339 shares
@ $2.2161, valued at
$186.9k
Sold 9,050 shares
@ $2.5149, valued at
$22.8k
|
|
| 03/02/2020 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,845 shares
@ $1.5, valued at
$4.3k
|
|
| 03/02/2020 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,625 shares
@ $1.5, valued at
$8.4k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 9,783 shares
@ $1.5, valued at
$14.7k
|
|
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,334 shares
@ $1.51, valued at
$8.1k
|
|
| 02/27/2020 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,465 shares
@ $1.51, valued at
$8.3k
|
|
| 01/13/2020 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0 |
|
| 01/13/2020 |
4
| O'Dowd Hugh (President & CEO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 240,000 shares
@ $0 |
|
| 01/13/2020 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0 |
|
| 01/13/2020 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0 |
|
| 11/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2019 |
4
| Siegel Jolie (VP, General Counsel) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 11/25/2019 |
4
| GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 11/25/2019 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 06/27/2019 |
4
| Zausner Meryl (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Kamen Robert (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
|
|
|